Skip to content
2000
Volume 19, Issue 2
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Oridonin is one of the major components isolated from Isodon rubescens, a traditional Chinese medicine, and it has been confirmed to exhibit many kinds of biological activities including anticancer, anti-inflammation, antibacterial and so on. However, the poor pharmaceutical property limits the clinical applications of oridonin. So many strategies have been explored in the purpose of improving the potencies of oridonin, and structure modification is one thus way. This review outlines the landscape of the recent development of oridonin derivatives with diverse pharmacological activities, mainly focusing on the biological properties, structure-activity relationships, and mechanism of actions.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557517666170417170609
2019-02-01
2025-07-06
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557517666170417170609
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test